FDA.reportPublic FDA data

Application 206815

Type
ANDA
Sponsor
NOVELGENIX THERAPS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001SODIUM POLYSTYRENE SULFONATESODIUM POLYSTYRENE SULFONATEPOWDER;ORAL, RECTAL454GM/BOTNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
13811-656Sodium Polystyrene SulfonateSodium Polystyrene SulfonateTrigen Laboratories, LLCANDACurrent
13811-656Sodium Polystyrene SulfonateSodium Polystyrene SulfonateTrigen Laboratories, LLCANDACurrent
62135-340Sodium Polystyrene SulfonateSodium Polystyrene SulfonateChartwell RX, LLCANDACurrent
62135-340Sodium Polystyrene SulfonateSodium Polystyrene SulfonateChartwell RX, LLCANDACurrent